Intervention

Placebo Comparator

ClinicalTrials.gov intervention label

Clinical trials58

Recruiting3

Common conditions25

Lead sponsors shown15

Clinical trials

58 shown

Nicotinic Acid for the Treatment of Alzheimer's DiseaseNCT06582706 · 2024-12-19

Improving Learning and Memory in Portuguese Patients With Multiple SclerosisNCT06723444 · 2024-12-05

Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 DiabetesNCT04874012 · 2021-06-12

A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease SubjectsNCT06964230 · 2026-10-26

NOT_YET_RECRUITING

PROMOTE: Effects of 5-HT4 Agonism on Cognition and Sleep in Peopl With Low MoodNCT07848477 · 2026-10-01

NOT_YET_RECRUITING

The BALANCE Study - Improving Glucose Control Through Prebiotic Gut Health Drink in Postmenopausal WomenNCT07565675 · 2026-06-10

NOT_YET_RECRUITING

VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's DiseaseNCT06874621 · 2025-03-03

ACTIVE_NOT_RECRUITING

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health ConditionsNCT06867718 · 2025-01-24

A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic AsthmaNCT06592768 · 2024-11-26

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System AtrophyNCT06671938 · 2024-10-24

MMP-9/NGAL Modulation by Piper Crocatum in Early Diabetic NephropathyNCT06676124 · 2024-06-15

A Phase 1b Study of PUR1800 in Patients With COPDNCT04759807 · 2021-01-04

Spironolactone in the Treatment of Heart FailureNCT04727073 · 2018-11-01

Probiotics in Metformin Intolerant Patients With Type 2 DiabetesNCT04089280 · 2018-10-16

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)NCT03456063 · 2018-04-24

A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic AsthmaNCT03138811 · 2017-12-18

Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For SchizophreniaNCT03781115 · 2017-11-20

ACTIVE_NOT_RECRUITING

Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)NCT03233308 · 2017-10-20

Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes MellitusNCT03117998 · 2017-09-19

Nicotinamide as an Early Alzheimer's Disease TreatmentNCT03061474 · 2017-07-12

Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes MellitusNCT02715193 · 2016-03-01

Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive DisorderNCT02484456 · 2015-10-14

Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes MellitusNCT02496000 · 2015-07-27

Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected AdultsNCT02771730 · 2015-03-01

Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years)NCT02425371 · 2014-09-01

Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour PeriodNCT02167555 · 2014-06-01

A Pilot Study to Characterize the Bioavailability and Plasma Profile of Potato Polyphenols in HumansNCT02167607 · 2014-06-01

Phase 2A Study of GM 608 in Mild to Moderate Parkinson DiseaseNCT01850381 · 2013-06-01

Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 WeeksNCT02810483 · 2012-12-01

Metformin as a Chemoprevention Agent in Non-small Cell Lung CancerNCT01717482 · 2012-10-01

Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 DiabetesNCT01477476 · 2012-03-01

The Clinical Effect of Monodisperse Fluticasone Propionate in AsthmaNCT01662778 · 2011-12-01

A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.NCT01464320 · 2011-11-01

A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid ArthritisNCT01430507 · 2011-09-01

Metformin in Women With Type 2 Diabetes in Pregnancy TrialNCT01353391 · 2011-05-25

Dyad Oxytocin Study (DOS)NCT02302209 · 2011-04-01

Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 DaysNCT01547169 · 2011-03-01

Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic RetinopathyNCT01373476 · 2011-03-01

Wound Edge Changes Following Treatment With SantylNCT01197898 · 2010-12-01

Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal DiseaseNCT01247090 · 2010-10-01

Study of KB003 In Biologics-Inadequate Rheumatoid ArthritisNCT00995449 · 2010-01-01

Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot UlcersNCT00804414 · 2008-10-01

A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic RetinopathyNCT00904592 · 2008-09-01

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line ChemotherapyNCT00676507 · 2008-07-01

Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 InfectionNCT00642707 · 2008-03-01

Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following ChemotherapyNCT01091974 · 2008-02-01

Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen ExtractNCT00622362 · 2008-01-01

BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid ArthritisNCT00458861 · 2007-03-01

SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor FluctuationsNCT00406588 · 2007-03-01

Safety Assessment of Lactobacillus Fermented Extract in Cancer Patients Undergoing ChemotherapyNCT00606970 · 2007-01-01

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson DiseaseNCT00335166 · 2006-11-01

Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological MarkersNCT00403520 · 2006-11-01

Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)NCT00455403 · 2006-04-01

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's PatientsNCT00141661 · 2005-10-01

Rituximab in New Onset Type 1 DiabetesNCT00279305 · 2005-08-01

The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological PhenotypesNCT01832766 · 2005-06-01

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period DyskinesiasNCT01172379 · 2004-05-01

Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's DiseaseNCT00040404 · 2002-03-01

Common conditions

Leading sponsors

Chengdu University of Traditional Chinese Medicine2 Clinical Nutrition Research Center, Illinois Institute of Technology2 REMD Biotherapeutics, Inc.2 Solvay Pharmaceuticals2 University of Colorado, Denver2 Abbott1 Aerie Pharmaceuticals1 Assistance Publique - Hôpitaux de Paris1 BioArctic AB1 Biogen1 Biotec Pharmacon ASA1 Centro Hospitalar De São João, E.P.E.1 Cephalon1 Charite University, Berlin, Germany1 Columbia University1

Trial status mix

COMPLETED37

TERMINATED10

NOT_YET_RECRUITING3

RECRUITING3

ACTIVE_NOT_RECRUITING2

WITHDRAWN2

UNKNOWN1

Phase mix

PHASE228

PHASE111

PHASE311

NA9

PHASE43

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.